Trials / Conditions / Cisplatin Adverse Reaction

Cisplatin Adverse Reaction

9 registered clinical trials studyying Cisplatin Adverse Reaction.

Status	Trial	Sponsor	Phase
Unknown	Evaluation of the Effect of N-acetylcysteine in Preventing Cisplatin-Induced Toxicities in Cancer Patients NCT06297369	Ain Shams University	Phase 2
Terminated	Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors NCT05611307	Indiana University	—
Completed	Comparative Study of Different Doses of Magnesium as a Protective Agent in Nephrotoxicity in Cancer Patients NCT05586009	Tanta University	Phase 2
Unknown	Evaluation of the Effect of Genetic Polymorphisms in ERCC1 and OCT2 on the Occurrence and Severity of Cisplati NCT05247671	Ain Shams University	—
Unknown	Evaluation of the Effect of Rosuvastatin on Cisplatin-induced Nephrotoxicity and Ototoxicity NCT04817904	Cairo University	Phase 2
Completed	Protective Role of N-acetylcisteine From Cisplatin-induced Ototoxicity in Patients With Head and Neck Cancer NCT03400709	Hospital San Juan de Dios, Santiago	N/A
Unknown	Effects of DPP4 Inhibitor on Cisplatin Induced Acute Kidney Injury NCT02250872	Seoul National University Bundang Hospital	Phase 2 / Phase 3
Completed	Evaluation of Effects of Silymarin on Cisplatin Induced Nephrotoxicity in Upper Gastrointestinal Adenocarcinom NCT01829178	Tehran University of Medical Sciences	Phase 2 / Phase 3
Completed	Gabapentin in the Prevention of Nausea and Vomiting Induced by Chemotherapy NCT01052844	Faculdade de Medicina do ABC	Phase 3